Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy
Open Access
- 7 August 2007
- journal article
- Published by Springer Science and Business Media LLC in BMC Genomics
- Vol. 8 (1), 268
- https://doi.org/10.1186/1471-2164-8-268
Abstract
Background: The Down syndrome phenotype has been attributed to overexpression of chromosome 21 (Hsa21) genes. However, the expression profile of Hsa21 genes in trisomic human subjects as well as their effects on genes located on different chromosomes are largely unknown. Using oligonucleotide microarrays we compared the gene expression profiles of hearts of human fetuses with and without Hsa21 trisomy. Results: Approximately half of the 15,000 genes examined (87 of the 168 genes on Hsa21) were expressed in the heart at 18–22 weeks of gestation. Hsa21 gene expression was globally upregulated 1.5 fold in trisomic samples. However, not all genes were equally dysregulated and 25 genes were not upregulated at all. Genes located on other chromosomes were also significantly dysregulated. Functional class scoring and gene set enrichment analyses of 473 genes, differentially expressed between trisomic and non-trisomic hearts, revealed downregulation of genes encoding mitochondrial enzymes and upregulation of genes encoding extracellular matrix proteins. There were no significant differences between trisomic fetuses with and without heart defects. Conclusion: We conclude that dosage-dependent upregulation of Hsa21 genes causes dysregulation of the genes responsible for mitochondrial function and for the extracellular matrix organization in the fetal heart of trisomic subjects. These alterations might be harbingers of the heart defects associated with Hsa21 trisomy, which could be based on elusive mechanisms involving genetic variability, environmental factors and/or stochastic events.This publication has 63 references indexed in Scilit:
- NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21Nature, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Expression of Discoidin Domain Receptor 2 (DDR2) in the Developing HeartMicroscopy and Microanalysis, 2005
- Gene Expression Profile Analysis in Human T Lymphocytes from Patients with Down SyndromeAnnals of Human Genetics, 2004
- Collagen type VI expression during cardiac development and in human fetuses with trisomy 21The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 2003
- The reduction of NADH: Ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's diseaseLife Sciences, 2001
- Evidence against the Current Hypothesis of “Gene Dosage Effects” of Trisomy 21: ets-2, Encoded on Chromosome 21” Is Not Overexpressed in Hearts of Patients with Down SyndromeBiochemical and Biophysical Research Communications, 1999
- Whither Down syndrome critical regions?Human Genetics, 1997
- Congenital cardiovascular malformations associated with chromosome abnormalities: An epidemiologic studyThe Journal of Pediatrics, 1989
- Developmental geneticsCellular and Molecular Life Sciences, 1986